Insider Stock Trading History of Anido Armando


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Anido Armando since year 2005. The trader's CIK number is 1219866. At the time of this reporting, Anido Armando is the Chairman & Chief Exec. Officer of Zynerba Pharmaceuticals, Inc. . (stock ticker symbol ZYNE). See this page for all insider trading activities at Zynerba Pharmaceuticals, Inc. .

Note that in the past ANIDO ARMANDO also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Anido Armando since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-05-15 ZYNE Zynerba Pharmaceuticals, Inc. Buy 1,500 19.57 29,355
2017-05-12 ZYNE Zynerba Pharmaceuticals, Inc. Buy 3,500 19.76 69,160
2011-12-07 ADLR Adolor Corp Option Ex 150,000 2.03 304,800
2011-10-07 AUXL Auxilium Pharmaceuticals Inc Option Ex 5,275 7.81 41,197
2011-10-07 AUXL Auxilium Pharmaceuticals Inc Sale 5,275 14.23 75,047
2011-07-08 AUXL Auxilium Pharmaceuticals Inc Option Ex 5,275 7.81 41,197
2011-07-08 AUXL Auxilium Pharmaceuticals Inc Sale 5,275 20.30 107,103
2011-03-08 AUXL Auxilium Pharmaceuticals Inc Option Ex 10,555 7.81 82,434
2011-03-08 AUXL Auxilium Pharmaceuticals Inc Sale 10,555 23.02 242,997
2011-01-10 AUXL Auxilium Pharmaceuticals Inc Option Ex 10,555 7.81 82,434
2011-01-10 AUXL Auxilium Pharmaceuticals Inc Sale 10,555 23.22 245,055
2010-04-12 AUXL Auxilium Pharmaceuticals Inc Option Ex 30,000 7.81 234,300
2010-04-12 AUXL Auxilium Pharmaceuticals Inc Sale 30,000 33.07 992,129
2009-06-26 AUXL Auxilium Pharmaceuticals Inc Sale 30,000 30.30 908,910
2009-06-26 AUXL Auxilium Pharmaceuticals Inc Option Ex 30,000 7.81 234,300
2009-03-16 AUXL Auxilium Pharmaceuticals Inc Option Ex 30,000 7.81 234,300
2009-03-16 AUXL Auxilium Pharmaceuticals Inc Sale 30,000 29.73 891,960
2006-02-03 MEDI Medimmune Inc /de Option Ex 11,562 23.81 275,291
2006-02-03 MEDI Medimmune Inc /de Sale 11,562 32.67 377,788

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Anido Armando (Chairman & Chief Exec. Officer of Zynerba Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.